Lakewood-Amedex Biotherapeutics Inc (LABT) Price Prediction & Forecast

$2.300

-0.175 (-7.63%)At close

Price Predictions

1-Day Price Prediction

+0.64%

1-Week Prediction

-4.37%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

Open in app to unlock longer-horizon forecasts.

Loading chart…

LABT Prediction & Forecast by Similar Chart Analysis

Alphio's LABT stock price prediction model matches the current Lakewood-Amedex Biotherapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.31 (+0.64%). The 1-week path is $2.20 (-4.37%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Should I Buy Lakewood-Amedex Biotherapeutics Inc Stock?

Lakewood-Amedex Biotherapeutics Inc. (LABT) appears to be a good buy right now due to its recent surge of over 80% following positive updates on its antimicrobial drug candidate Nu-3, which aligns with market needs against antibiotic resistance. The stock is currently priced at $2.30, significantly below its 200-day simple moving average of $11.221, indicating potential for recovery. However, the company has reported a negative EPS of -2.66 in the latest quarter, which poses a risk to investors.